From:  Analysis of the benefit of anti-PD-1 monotherapy according to NGS-diagnosed genetic alterations in patients with non-small cell lung cancer

Molecular data on whole cohort

VariableWhole cohort (n = 107)
Tumor cells
        < 20%7 (7%)
        20–50%45 (42%)
        > 50%40 (37%)
        Missing15 (14%)
Number of mutations
        012 (11%)
        139 (37%)
        243 (40%)
        ≥ 313 (12%)
Return to article view